Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arkansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arkansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arkansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kewen Jauss (NPI 1609984368)

Field	Value
Entity Type	Individual
Organization	Kewen Jauss
Address	8901 Carti Way
City	Little Rock
State	AR
ZIP	72205
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	August 25, 2006

Payer Source	Total Paid
Medicare	$2.8M
Medicaid	$0

Key Findings

This provider is principally an oncology/infusion practice based on its Medicare code mix: the top three revenue drivers are J9271, J9299, and J0897 (checkpoint inhibitors and bone-supportive biologic agents) and the profile includes chemotherapy administration codes such as 96413 and infusion administration codes like 96365/96367. High volumes of drug administration codes alongside chemotherapy and infusion CPTs indicate the practice operates an on-site infusion program rather than primarily office-based evaluative care.

Revenue is highly concentrated in a small set of reimbursements: the precomputed top 3 Medicare codes by revenue account for 62.2% of this provider's total Medicare revenue, with J9271 alone representing $980.4K revenue (37.6% of this provider's total Medicare revenue). This concentration makes the provider’s Medicare financial performance sensitive to utilization and pricing for a handful of high-impact drugs.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2.8M and there is no Medicaid billing on file, so Medicaid does not appear in this provider’s documented public payer mix. This suggests operational and revenue risk is concentrated in the Medicare market and that analyses of state Medicaid networks will not capture this provider’s activity.

The provider’s competitive standing is mixed across codes: for high-revenue immunotherapy drugs the provider’s national position is around typical volumes (J9271 ranks #283 of 1841, 84th percentile; J9299 ranks #190 of 505, 62th percentile), while certain supportive and admin services show unusually high national standing (J0885 ranks #13 of 953, 99th percentile; 99214 ranks #2133 of 479517, 100th percentile). In other words, the practice is not an outlier for the headline immunotherapies but is a major outlier for several administration and supportive-care codes, suggesting specialization in drug delivery and associated patient management.

Multiple codes are flagged as statistical outliers or notably above typical national volume, reinforcing operational emphasis on high-throughput infusion and clinic throughput: J0885 is labeled an "extreme outlier" (23.2K claims, $139.4K revenue), 96375 is an "extreme outlier" (1.4K claims, $15.4K revenue), and 96372 is an "extreme outlier" (968 claims, $9.7K revenue), while J1437 is "notably above typical" (10.7K claims, $181.9K revenue). These labels point to exceptional local scale for certain injectable agents and infusion encounters relative to national peers.

Operational support services and monitoring are robust: the provider reports substantial lab and monitoring CPT volumes (88185: 2.3K claims, $36.9K revenue; 80053: 2.4K claims, $23.8K revenue; 85025: 2.6K claims, $21.1K revenue), which aligns with ongoing systemic therapy requiring frequent laboratory surveillance. The combination of diagnostic panels and flow cytometry activity supports a care model that couples infusion-based treatment with in-house or closely coordinated lab services.

The provider shows long tenure in Medicare billing, with the NPI enumerated 2006-08-25 (~20 years ago), which is consistent with an established practice and may explain sustained high volumes for recurring administration codes and laboratory monitoring over time. This longevity suggests experience in managing infusion workflows and payer billing patterns for oncology therapies.

Some high-revenue lines are driven by very large claim counts at modest per-claim payments, underscoring scale as the revenue engine for parts of the portfolio: for example, J0885 has 23.2K claims at an $6 avg paid/claim generating $139.4K revenue, and J9271 has 22.8K claims at a $43 avg paid/claim generating $980.4K revenue. These observations indicate the practice’s revenue mix relies on both high-volume low-unit items and high-dollar-per-unit biologics, a dual strategy that concentrates revenue in drug administration throughput and costly immunotherapies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

104 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	22,800	$40	$980.4K
J9299	Injection, nivolumab, 1 mg	18,480	$20	$443.5K
J0897	Injection, denosumab, 1 mg	11,100	$20	$199.8K
J1437	Injection, ferric derisomaltose, 10 mg	10,700	$20	$181.9K
J9264	Injection, paclitaxel protein-bound particles, 1 mg	16,600	$10	$166K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,760	$90	$151.4K
J0885	Injection, epoetin alfa, (for non-esrd use), 1000 units	23,240	$10	$139.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	820	$90	$69.5K
88185	The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with…	2,300	$20	$36.9K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	800	$40	$28.8K

Showing 1–10 of 104

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 104 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arkansas Distribution

Kewen Jauss — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arkansas

Full comparison — all codes billed, vs. state median

104 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	16	40	20,700	$40	$896.3K
J9299	12	30	15,660	$20	$432.9K
J1569	13	10	2,560	$40	$120.3K
J1437	3	20	6,450	$20	$107.8K
J9264	1	10	9,300	$10	$96.2K
J0897	19	160	2,580	$20	$89.7K
J2506	5	10	580	$80	$40.4K
J0885	1	40	4,070	$10	$38K
96413	10	80	380	$90	$36.6K
J9217	50	50	100	$130	$20K

Showing 1–10 of 104

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kewen Jauss, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Central Arkansas Radiation Therapy Institute Inc	AR	Hematology & Oncology Physician	$0	$11M
Central Arkansas Radiation Therapy Institute Inc	AR	Radiation Oncology Physician	$6.7M	$3.6M
Kamal Patel	AR	Hematology & Oncology Physician	$5.7M	$0
Ryan Hall	AR	Hematology & Oncology Physician	$4.6M	$0
Balagopalan Nair	AR	Hematology & Oncology Physician	$4.1M	$0
Lawrence Mendelsohn	AR	Hematology & Oncology Physician	$3.4M	$0
Jamie Burton	AR	Hematology & Oncology Physician	$2.8M	$0
Mariann Harrington	AR	Hematology & Oncology Physician	$2.7M	$0
Appalanaidu Sasapu	AR	Hematology & Oncology Physician	$2.6M	$0
Derek Middleton	AR	Hematology & Oncology Physician	$2.5M	$0

Nearby Providers

Other providers in the same ZIP code as Kewen Jauss, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Of Arkansas For Medical Sciences	AR	General Acute Care Hospital	$0	$87.2M
University Of Arkansas For Medical Sciences	AR	Internal Medicine Physician	$0	$28.6M
University Of Arkansas For Medical Sciences	AR	Pediatrics Physician	$0	$27.6M
Arkansas Department Of Health Immunizations	AR	Public Health or Welfare Agency	$0	$19.3M
Baptist Health	AR	General Acute Care Hospital	$0	$16.4M
Arkansas Department Of Health Family Planning Clinic	AR	Public Health or Welfare Agency	$0	$15.6M
Pediatrix Medical Group Of Arkansas PA	AR	Neonatal-Perinatal Medicine Physician	$0	$14.6M
Chenal Family Therapy, Plc	AR	Mental Health Counselor	$0	$12.2M
Francis A. Allen School For Exceptional Children, Inc.	AR	Developmentally Disabled Services Day Training Agency	$0	$11.9M
Arkansas Department Of Health Std	AR	Public Health or Welfare Agency	$0	$8.4M

Kewen Jauss — Billing Profile & Reimbursement Data

Sign up for Kewen Jauss — Billing Profile & Reimbursement Data policy alerts

Kewen Jauss — Billing Profile & Reimbursement Data

Sign up for Kewen Jauss — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References